B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA
Clinical trials for B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists Re-Engineer Patients' own cells to hunt blood cancer
Disease control Recruiting nowThis study is testing a personalized cell therapy for adults with advanced B-cell leukemias that have not responded to standard drugs. Doctors take a patient's own immune cells, modify them in a lab to target a protein (CD19) found on their cancer cells, and then infuse them back…
Matched conditions: B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New shot aims to shield cancer patients from dangerous infections
Prevention Recruiting nowThis study is testing whether adding an antibody-boosting medication called Xembify to standard care can help prevent serious bacterial infections in adults with certain blood cancers. Participants must have low antibody levels and a history of severe or frequent infections. The …
Matched conditions: B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE3 • Sponsor: Grifols Therapeutics LLC • Aim: Prevention
Last updated Mar 30, 2026 14:35 UTC